Influence of preinfarction angina on the release kinetics of endothelial progenitor cells and cytokines during the week after infarction

Eur J Clin Invest. 2011 Nov;41(11):1220-6. doi: 10.1111/j.1365-2362.2011.02529.x. Epub 2011 Apr 25.

Abstract

Background: Preinfarction angina, a possible form of ischaemic preconditioning, improves the prognosis in patients who experience a major ischaemic event; though the associated pathophysiology is not yet fully understood. The aim of this study was to determine the possible involvement of endothelial progenitor cells (EPC), the vascular endothelial growth factor (VEGF) and the hepatocyte growth factor (HGF) in the development of preinfarction angina.

Methods and results: We studied 41 patients (60·5 ± 12 years; 34% women) and 14 healthy controls; 43·9% of the patients had preinfarction angina. No differences were found in the baseline characteristics of the two groups. Although the EPC, VEGF and HGF were raised as compared with the control group, no significant differences were found according to the presence or absence of preinfarction angina in the levels of EPC (baseline, P = 0·25; day 3, P = 0·11; day 7, P = 0·32), VEGF (baseline, P = 0·96; day 3, P = 0·06; day 7, P = 0·57) or HGF (baseline, P = 0·18; day 3, P = 1; day 7, P = 0·86). An association was seen in the patients who had preinfarction angina between the EPC levels at baseline and on days 3 and 7 and the HGF on admission with the time from the angina to the STEMI (β = -0·070; β = -0·066; β = -0·081; β = -80·16; P < 0·05), showing a reduction in the level of EPC cells for each hour passed since the event.

Conclusions: No differences were found in the release kinetics of EPC, VEGF or HGF after a first infarction according to whether the patients had angina during the week before the infarction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angina, Unstable / physiopathology*
  • Case-Control Studies
  • Endothelium, Vascular / metabolism*
  • Hepatocyte Growth Factor / blood*
  • Humans
  • Immunophenotyping
  • Middle Aged
  • Myocardial Infarction / physiopathology*
  • Statistics as Topic
  • Stem Cells / metabolism*
  • Time Factors
  • Vascular Endothelial Growth Factor A / blood*

Substances

  • Vascular Endothelial Growth Factor A
  • Hepatocyte Growth Factor